Fintel reports that on April 22, 2026, UBS upgraded their outlook for Biogen (NasdaqGS:BIIB) from Neutral to Buy.
Analyst Price Forecast Suggests 11.45% Upside
As of April 14, 2026, the average one-year price target for Biogen is $211.91/share. The forecasts range from a low of $151.50 to a high of $288.75. The average price target represents an increase of 11.45% from its latest reported closing price of $190.14 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Biogen is 10,433MM, an increase of 5.48%. The projected annual non-GAAP EPS is 15.00.
What is the Fund Sentiment?
There are 1,016 funds or institutions reporting positions in Biogen. This is an decrease of 631 owner(s) or 38.31% in the last quarter. Average portfolio weight of all funds dedicated to BIIB is 0.10%, an increase of 31.38%. Total shares owned by institutions decreased in the last three months by 4.63% to 139,031K shares. 
The put/call ratio of BIIB is 0.97, indicating a bullish outlook.
What are Other Shareholders Doing?
Primecap Management holds 14,758K shares representing 10.06% ownership of the company. In its prior filing, the firm reported owning 14,955K shares , representing a decrease of 1.33%. The firm increased its portfolio allocation in BIIB by 22.54% over the last quarter.
Geode Capital Management holds 4,199K shares representing 2.86% ownership of the company. In its prior filing, the firm reported owning 4,069K shares , representing an increase of 3.11%. The firm increased its portfolio allocation in BIIB by 25.48% over the last quarter.
Wellington Management Group Llp holds 3,551K shares representing 2.42% ownership of the company. In its prior filing, the firm reported owning 4,247K shares , representing a decrease of 19.58%. The firm increased its portfolio allocation in BIIB by 5.28% over the last quarter.
Point72 Asset Management holds 2,813K shares representing 1.92% ownership of the company. In its prior filing, the firm reported owning 3,873K shares , representing a decrease of 37.67%. The firm decreased its portfolio allocation in BIIB by 39.01% over the last quarter.
Norges Bank holds 2,639K shares representing 1.80% ownership of the company. In its prior filing, the firm reported owning 0K shares , representing an increase of 100.00%.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
